Crinetics Pharmaceuticals In shares owned by Citigroup
Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Crinetics Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Crinetics Pharmaceuticals In held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crinetics Pharmaceuticals In by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $3.3M | 65k | 51.11 |
| 2024-06-30 | $1.4M | 31k | 44.78 |
| 2024-03-31 | $12M | 248k | 46.81 |
| 2023-12-31 | $3.6M | 102k | 35.60 |
| 2023-09-30 | $2.5M | 84k | 29.50 |
| 2023-03-31 | $1.7M | 104k | 16.06 |
| 2022-12-31 | $894k | 49k | 18.30 |
| 2022-09-30 | $1.4M | 71k | 19.64 |
| 2021-12-31 | $1.5M | 52k | 28.42 |
| 2021-03-31 | $43k | 2.8k | 15.32 |
| 2020-12-31 | $145k | 10k | 14.13 |
| 2020-09-30 | $78k | 5.0k | 15.58 |
| 2020-06-30 | $115k | 6.6k | 17.50 |
| 2020-03-31 | $47k | 3.2k | 14.61 |
| 2019-12-31 | $56k | 2.3k | 24.88 |
| 2019-09-30 | $19k | 1.2k | 16.39 |
| 2019-06-30 | $92k | 3.6k | 25.19 |
| 2019-03-31 | $61k | 2.7k | 22.63 |
| 2018-12-31 | $44k | 1.5k | 29.33 |
| 2018-09-30 | $56k | 1.9k | 28.78 |